Reading Time: 4 minutes
Every December, we showcase some of the biggest diabetes advances that made headlines throughout the year. With the day-to-day grind of living with diabetes, it can be easy to forget how many cool things have actually happened!
Companies that had big-time product launches or significant FDA approvals probably felt good about their accomplishments this year, but little did they know they’d also be receiving special recognition in our first-ever Golden Glucose Awards. From new medications to innovative diabetes technology, 2026 gave us lots to celebrate!
And the winners are…
Category: Wackiest Drug Name
🏆 The Winners Are…
🌟 Awiqli and Onswik 🌟
This was one of the toughest categories to call – our judges couldn’t decide between these once-weekly basal insulins that were approved this year. Although Awiqli and Onswik sound like they could also be lamps from IKEA, their names make much more sense than most medications out there (Awiqli for “a-weekly” and Onswik for “once-a-week”). Both of these new weekly insulins offer people with type 2 diabetes fewer injections and a potentially simpler and more efficient way to manage their diabetes.
Category: Easiest Pill to Swallow
🏆 The Winner Is…
🌟 Foundayo 🌟
Lilly’s GLP-1 pill Foundayo was FDA-approved this year, joining Novo Nordisk’s Ozempic Pill and Wegovy Pill. Foundayo can be taken any time of day, with or without food or water. This could be a big deal for anyone who doesn’t want to wait 30 minutes for their first sip of coffee (which can have dangerous consequences for some of us).
Category: Coolest Way to Deliver Insulin In Front of Your Friends
🏆 The Winner Is…
🌟 Inhaled Insulin Afrezza 🌟
Inhaled insulin Afrezza was approved in May for kids ages six and older with type 1 or type 2 diabetes, giving kids and teens a more discreet way to dose insulin without needles or insulin pens. Afrezza offers more flexibility around unpredictable meals and schedules, and its rapid onset and shorter duration mean less insulin “hanging around” during sports and other activities. Better post-meal highs and less delayed lows!
Category: “I Don’t Know How to Put This, but I’m Kind of a Big Deal”
🏆 The Winner Is…
🌟 Abbott’s Libre DUO 10 Day System 🌟
One of the biggest advancements this year was Abbott’s Libre DUO 10 Day system, the world’s first-ever sensor that continuously monitors both glucose and ketones. The sensor alerts you when your ketone levels rise, giving you time to catch DKA before it becomes an emergency. This is especially important when you’re sick, experiencing an insulin pump infusion line failure, or taking an SGLT2 inhibitor. Abbott plans to launch Libre DUO this month.
Category: Best Investigation of a Crime Nobody Committed
🏆 The Winner Is…
🌟 The Person Who Thinks They Caught You Eating Cake 🌟
The next time someone asks you, “Are you allowed to eat that?” you can tell them, “Yes, the Diabetes Supreme Court approved my appeal and I can eat whatever the heck I want. So back away from my frosting, or things are going to get real.”
Category: Size Does Matter
🏆 The Winner Is…
🌟 MiniMed Flex AID System 🌟
MiniMed shrunk things down this year with the launch of their smallest, sleekest, and first-ever screenless insulin pump called MiniMed Flex. About half the size of the MiniMed 780G, Flex still has a 300-unit reservoir and uses the same algorithm, but everything is controlled from a smartphone using the MiniMed app. Dr. Pettus took the Flex out for a test drive and shared his first impressions in this detailed review.
Category: Best Insulin Pump to Make You Crave a Mojito
🏆 The Winner Is…
🌟 Beta Bionics Mint Patch Pump 🌟
Beta Bionics’ first-ever patch pump Mint actually stands for “Mini Insulin Therapy”, but you can still drink your favorite minty beverage while wearing it. Mint has a two-piece reusable and disposable design, a 200-unit reservoir, three days of wear time, and it doesn’t require recharging. Beta Bionics is also working on a next-gen algorithm called 3D Intelligence that will eventually power both the Mint and iLet. Mint is expected to launch in the U.S. in early 2027.
Category: It’s About Freakin’ Time
🏆 The Winner Is…
🌟 Kerendia 🌟
After decades of waiting (seriously…like 30 years), type 1s finally got an approved medication to address a major complication of the condition – kidney disease. Kerendia helps protect the kidneys by reducing inflammation and scarring that can contribute to worsening kidney disease. In the FINE-ONE clinical trial, Kerendia reduced uACR (a key marker of kidney damage) by 25% compared with placebo. Kerendia’s approval could be a sign that treatments for type 1 diabetes are finally expanding beyond insulin.
Category: Most Exciting CGM to Get Under Your Skin…In a Good Way
🏆 The Winner Is…
🌟 Senseonics Freedom CGM 🌟
Senseonics is on a mission to make CGMs practically invisible. They recently started their first in-human trial of Freedom, an investigational CGM that doesn’t require an external transmitter. Freedom has an implanted sensor designed to last a full year, with a built-in battery and Bluetooth communication to smartphones. Even though it’s still early in development, Senseonics is targeting a potential launch in 2028. Get ready for “naked” showers!
Category: Diabetes Tech for Low-Tech Lovers
🏆 The Winner Is…
🌟 Modular Medical’s Pivot Tubeless Patch Pump 🌟
Sometimes you just wanna keep things simple. The Pivot patch pump is for people who want the benefits of pump therapy without all the bells and whistles of AID systems. Pivot is a tubeless patch pump that delivers continuous basal insulin and mealtime boluses with the push of a button. It does not integrate with a CGM, but you can still wear one to see your blood sugar in real time and figure out your own doses of insulin.
Category: Most Optimistic Bedtime Announcement from Someone with Diabetes
🏆 The Winner Is…
🌟 “My Blood Sugar Looks Good…I Should Sleep Great Tonight.” 🌟
Diabetes would like to thank you for submitting your plans, but your request has been denied.
Category: Most Likely to Keep Beta Cells Stayin’ Alive, Stayin’ Alive 🕺
🏆 The Winner Is…
🌟 Tzield 🌟
Tzield received a new FDA indication to help kids and teens ages 8–17 diagnosed with stage 3 NEW ONSET type 1 diabetes preserve their insulin-producing beta cells a little longer. Previously, Tzield was only approved to delay the onset of stage 3 T1D in people with stage 2 of the condition. Tzield is now the first FDA-approved disease-modifying therapy that can target the underlying autoimmune attack after type 1 diabetes has been diagnosed.
Category: Studies Supporting CGM Access for People with Type 2 Diabetes Not on Insulin
🏆 The Winner Is…
🌟 The CONNECT Study 🌟
For too long, CGMs have been considered a tool primarily for people with type 1 diabetes and those with insulin-treated type 2 diabetes. The CONNECT study looked at whether a CGM could meaningfully improve blood sugar control for people with type 2 not on insulin. Results showed that people with type 2 diabetes using a Dexcom CGM had greater improvements in A1c and time in range compared to those not using a CGM. This is aligned with what we have been saying for years…anyone with any time of diabetes can benefit from using a CGM.
And last but not least…
Category: Best Diabetes Music Video with a Cheeky Centerfold
🏆 The Winner Is…
🌟 TCOYD’s Diabetes Superstar 🌟
You just have to watch for yourself (video below)…

That’s a Wrap!
While there were several standout advances this year, there were also many other developments that – though maybe not as splashy – still had a big impact on the ease with which we live with diabetes. There were new CGM and pump integrations, expanded indications for medications, pumps, and CGMs, and continued progress from companies around the world who are dedicated to finding a functional cure for type 1 diabetes.
That’s a wrap for our 2026 Golden Glucose Awards – the only awards show where “I’d like to thank my drug dealer” means your pharmacist. And to our pancreases, who once again contributed absolutely nothing to this year’s achievements…thanks for keeping us motivated. 😉
Explore our resource library and video vault, and subscribe to our monthly digital newsletter for more tips, tools, and expert guidance on how to take control of your diabetes.
Additional Resources:
- Podcast: Once-Weekly Basal Insulin for Type 2 Diabetes
- Do GLP-1 Pills Work as Well as Injections?
- Needle-Free Insulin for Kids Is Here!
- I Switched from the MiniMed 780G to the Flex: A Real-World Look at What Got Better, What Got Smaller, and What I Miss at 2:00 am
- Finally, a New Drug for Type 1 Diabetes! Kerendia Approved to Treat Kidney Disease in T1D

Our goal is to protect your personal health information. Please keep your questions general and do not post personal medical information here. If you have a specific question, please email events@tcoyd.org.